Most patients do well on topical therapy, but innovation in IOP-lowering drops remains essential. One might ask why topical eye drop medications remain the mainstay of glaucoma therapy in the US and ...

Glaucoma is one of the three leading causes of blindness in Germany and worldwide. This neurodegenerative disease progressively damages the retinal nerve fibres, leading to irreversible vision loss.

Glaucoma happens when a fluid called aqueous humor builds up in your eye, increasing pressure on the optic nerve and damaging it. Around 4.2 million people in the U.S. have the condition, although not ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Dry eye prevalence based on Ocular Surface Disease Index ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Average IOP reductions were 23.04% at 6 months and 25.74 ...

NEW YORK (Reuters Health) - People in most need of sight-preserving eyedrops may be the least successful in landing the therapy in their eyes, suggests a new study. Buildup of internal eye pressure is ...

Using pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients with glaucoma and reduce the need for future medications, according to new ...

Discover how tiny, cutting‑edge surgical tools are transforming glaucoma care with a gentler, less invasive approach. Learn why Moran Eye Center experts use MIGS to help protect vision earlier and ...

The early part of the year brings not only cold weather, but also awareness for the “sneak thief of sight,” glaucoma. The devastation that the disease can bring is particularly challenging for African ...

ANSWER: Although your glaucoma specialist is correct that very low blood pressure can cause low blood flow to the retina, I ...

AND JESS, YOU SAY THIS COULD BE A GAME CHANGER. YOU KNOW, IT REALLY CAN. ABOUT 3 MILLION AMERICANS HAVE GLAUCOMA AND THIS NEW TREATMENT IS BASICALLY AN IMPLANTABLE DRUG FOR THE EYE. AND DOCTORS SAY IT ...